| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |